Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0091 Transporter Info | ||||
Gene Name | SLC13A1 | ||||
Transporter Name | Sodium/sulfate cotransporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg05146599) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.13E-02; Z-score: 5.58E-01 | ||
Methylation in Case |
8.54E-01 (Median) | Methylation in Control | 8.14E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC13A1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
3'UTR (cg00928751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 6.47E-07; Z-score: -1.40E+00 | ||
Methylation in Case |
7.96E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in hepatocellular carcinoma | [ 2 ] | |||
Location |
TSS1500 (cg03564727) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.40E+00 | Statistic Test | p-value: 2.27E-11; Z-score: -4.97E+00 | ||
Methylation in Case |
5.90E-01 (Median) | Methylation in Control | 8.26E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC13A1 in hepatocellular carcinoma | [ 2 ] | |||
Location |
TSS200 (cg00895997) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 6.77E-06; Z-score: -1.79E+00 | ||
Methylation in Case |
3.66E-01 (Median) | Methylation in Control | 4.85E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC13A1 in hepatocellular carcinoma | [ 2 ] | |||
Location |
1stExon (cg22024657) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 9.76E-05; Z-score: -5.02E-01 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 7.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC13A1 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg03993154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 1.81E-02; Z-score: -3.79E-01 | ||
Methylation in Case |
1.15E-01 (Median) | Methylation in Control | 1.27E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in bladder cancer | [ 3 ] | |||
Location |
TSS200 (cg00895997) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.57E+00 | Statistic Test | p-value: 3.71E-08; Z-score: -1.37E+01 | ||
Methylation in Case |
4.35E-01 (Median) | Methylation in Control | 6.82E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC13A1 in bladder cancer | [ 3 ] | |||
Location |
1stExon (cg22024657) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 7.53E-04; Z-score: -6.48E+00 | ||
Methylation in Case |
8.16E-01 (Median) | Methylation in Control | 8.97E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in lung adenocarcinoma | [ 4 ] | |||
Location |
TSS200 (cg00895997) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 3.07E-02; Z-score: -2.19E+00 | ||
Methylation in Case |
7.09E-01 (Median) | Methylation in Control | 7.64E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC13A1 in lung adenocarcinoma | [ 4 ] | |||
Location |
Body (cg03993154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 1.55E-04; Z-score: 3.42E+00 | ||
Methylation in Case |
1.73E-01 (Median) | Methylation in Control | 1.30E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in papillary thyroid cancer | [ 5 ] | |||
Location |
TSS200 (cg00895997) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.59E-03; Z-score: -9.08E-01 | ||
Methylation in Case |
7.89E-01 (Median) | Methylation in Control | 8.23E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC13A1 in papillary thyroid cancer | [ 5 ] | |||
Location |
Body (cg03993154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 1.77E-07; Z-score: -1.27E+00 | ||
Methylation in Case |
1.23E-01 (Median) | Methylation in Control | 1.52E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in systemic lupus erythematosus | [ 6 ] | |||
Location |
TSS200 (cg00895997) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.67E-02; Z-score: -2.14E-01 | ||
Methylation in Case |
7.57E-01 (Median) | Methylation in Control | 7.74E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in atypical teratoid rhabdoid tumor | [ 7 ] | |||
Location |
1stExon (cg22024657) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 8.58E-17; Z-score: -2.52E+00 | ||
Methylation in Case |
6.88E-01 (Median) | Methylation in Control | 8.92E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC13A1 in atypical teratoid rhabdoid tumor | [ 7 ] | |||
Location |
Body (cg03993154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.15E-04; Z-score: -7.25E-01 | ||
Methylation in Case |
9.42E-01 (Median) | Methylation in Control | 9.55E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in breast cancer | [ 8 ] | |||
Location |
1stExon (cg22024657) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 9.14E-05; Z-score: -1.10E+00 | ||
Methylation in Case |
8.25E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC13A1 in breast cancer | [ 8 ] | |||
Location |
Body (cg03993154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 5.08E-08; Z-score: 1.96E+00 | ||
Methylation in Case |
1.16E-01 (Median) | Methylation in Control | 8.17E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg03993154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.46E+00 | Statistic Test | p-value: 1.59E-06; Z-score: 2.27E+00 | ||
Methylation in Case |
1.96E-01 (Median) | Methylation in Control | 1.34E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A1 in prostate cancer | [ 10 ] | |||
Location |
Body (cg14084826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 4.97E-02; Z-score: -3.85E+00 | ||
Methylation in Case |
5.91E-01 (Median) | Methylation in Control | 7.98E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.